← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2014Last known activity
Sep 15, 2024
Timeline
2010s
- Jun 1, 2014
Ark Biosciences Inc.— Founded
Drugs by trial phase (6 distinct, 17 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (31)
- NCT06591845Lead sponsorPhase 1Sep 15, 2024
- NCT06359899Lead sponsorPhase 3May 31, 2024
- NCT06996704Lead sponsorPhase 1Feb 29, 2024
- NCT06775405Lead sponsorPhase 3Feb 29, 2024
- NCT06942299Lead sponsorPhase 2Jul 20, 2023
- NCT05434897CollaboratorPhase 1/Phase 2Jul 31, 2022
- NCT05434897Lead sponsorPhase 1/Phase 2Jul 31, 2022
- NCT05424887CollaboratorPhase 2Jul 31, 2022
- NCT05424887Lead sponsorPhase 2Jul 31, 2022
- NCT04926116Study directorPhase 1Jun 9, 2021
- NCT04926116CollaboratorPhase 1Jun 9, 2021
- NCT04926116Lead sponsorPhase 1Jun 9, 2021
- NCT04788017Study directorPhase 1Apr 5, 2021
- NCT04788017Lead sponsorPhase 1Apr 5, 2021
- NCT04231968Study directorPhase 3Feb 29, 2020
Details
- Founded
- Shanghai, CN Jun 1, 2014
- Last known activity
- Sep 15, 2024